Details

---

Manufacturer
KOTRA PHARMA (M) SDN. BHD.
 
Contents
Lamivudine
 
Indication
HIV infection.
 
Instruction
May be taken with or without food.Adult 300 mg once daily, in combination w/ other antiretrovirals
 
Drug interaction
Trimethoprim. Increased lamivudine exposure by about 40% w/ trimethoprim/ sulphamethoxazole. May inhibit the intracellular phosphorylation of zalcitabine.